Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
Safety and Efficacy Study of Ara-c at 18 gm/m2 Versus 12 gm/m2 for 3 Cycles Each in AML Consolidation
- Status
- UNKNOWN
- Phase
- PHASE3
Busulfan Pharmacokinetic Analysis and GST Pharmacogenetic Profile in Adults Undergoing Hematological Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- N/A
Safety and Efficacy Study of PRI-724 in Subjects With Advanced Myeloid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of the Predictive Marker FLT in Patients Suffering From AML
- Status
- WITHDRAWN
- Phase
- N/A
Registry on Hypomethylating Agents in Myeloid Neoplasms
- Status
- COMPLETED
- Phase
- N/A
Consolidation Therapy for Acute Myeloid Leukemia Guided by Leukemia Stem Cell Behavior
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
3 Anthracyclines, 2 Types of Consolidation With Different ARA-C Doses and Maintenance in Adult Acute Myeloid Leukemia
- Status
- UNKNOWN
- Phase
- PHASE4
Lenalidomide as Consolidation and Maintenance in Adults >/= 60 Years of Age With AML Following Standard Induction
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study of AKN-028 in Patients With Acute Myelogenous Leukemia
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning
- Status
- COMPLETED
- Phase
- PHASE2
A Study To Evaluate PF-04449913 With Chemotherapy In Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
TevaGastrim for Stem Cell Mobilization Sibling Donors
- Status
- COMPLETED
- Phase
- PHASE2
VIDAZA-DLI Pre-emptive Azacitidine and Donor Lymphocyte Infusions Following Allogeneic Hematopoietic Stem Cell Transplantation for High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
Dose Escalation of Clofarabine in Combination With Cytarabine and Idarubicin as Induction Therapy in High Risk AML
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Phase I/II Study of Combination of Sorafenib, Vorinostat, and Bortezomib for the Treatment of Acute Myeloid Leukemia With Complex- or Poor-risk (Monosomy 5/7) Cytogenetics or FLT3-ITD Positive Genotype
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
CNDO-109-AANK for AML in First Complete Remission (CR1)
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies
- Status
- COMPLETED
- Phase
- NA
Administration of Donor T Cells With the Caspase-9 Suicide Gene
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Safety, Tolerability, Pharmacokinetics and Efficacy of AZD1208 in Acute Myelogenous Leukemia (AML) Patients
- Status
- TERMINATED
- Phase
- PHASE1